{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:07:48Z","timestamp":1789729668204,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T00:00:00Z","timestamp":1387929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00535-013-0891-1","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T04:17:59Z","timestamp":1387858679000},"page":"1264-1273","source":"Crossref","is-referenced-by-count":39,"title":["Interleukin-6 upregulates Th17 response via mTOR\/STAT3 pathway in acute-on-chronic hepatitis B liver failure"],"prefix":"10.1007","volume":"49","author":[{"given":"Hee Yeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Yeon","family":"Jhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kyeong","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ha","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Woo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,25]]},"reference":[{"key":"891_CR1","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1056\/NEJMe058119","volume":"352","author":"AS Lok","year":"2005","unstructured":"Lok AS. The maze of treatments for hepatitis B. N Engl J Med. 2005;352:2743\u20136.","journal-title":"N Engl J Med"},{"key":"891_CR2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","volume":"2","author":"JH Kao","year":"2002","unstructured":"Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395\u2013403.","journal-title":"Lancet Infect Dis"},{"key":"891_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3:269\u201382.","journal-title":"Hepatol Int"},{"key":"891_CR4","doi-asserted-by":"crossref","unstructured":"Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, et al. Acute-on chronic liver failure. J Hepatol. 2012;57:1336\u201348.","DOI":"10.1016\/j.jhep.2012.06.026"},{"key":"891_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","volume":"18","author":"LE Harrington","year":"2006","unstructured":"Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006;18:349\u201356.","journal-title":"Curr Opin Immunol"},{"key":"891_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.smim.2007.10.007","volume":"19","author":"T Korn","year":"2007","unstructured":"Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol. 2007;19:362\u201371.","journal-title":"Semin Immunol"},{"key":"891_CR7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10620-011-1930-5","volume":"57","author":"LY Wang","year":"2012","unstructured":"Wang LY, Meng QH, Zou ZQ, Fan YC, Han J, Qi ZX, et al. Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci. 2012;57:667\u201374.","journal-title":"Dig Dis Sci"},{"key":"891_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/vim.2010.0135","volume":"24","author":"S Zhai","year":"2011","unstructured":"Zhai S, Zhang L, Dang S, Yu Y, Zhao Z, Zhao W, et al. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol. 2011;24:303\u201310.","journal-title":"Viral Immunol"},{"key":"891_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2172-12-47","volume":"12","author":"Y Niu","year":"2011","unstructured":"Niu Y, Liu H, Yin D, Yi R, Chen T, Xue H, et al. The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol. 2011;12:47.","journal-title":"BMC Immunol"},{"key":"891_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.23273","volume":"51","author":"JY Zhang","year":"2010","unstructured":"Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51:81\u201391.","journal-title":"Hepatology"},{"key":"891_CR11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967\u201374.","journal-title":"Nat Immunol"},{"key":"891_CR12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007;8:942\u20139.","journal-title":"Nat Immunol"},{"key":"891_CR13","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","volume":"282","author":"C Schindler","year":"2007","unstructured":"Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 2007;282:20059\u201363.","journal-title":"J Biol Chem"},{"key":"891_CR14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","volume":"30","author":"GM Delgoffe","year":"2009","unstructured":"Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 2009;30:832\u201344.","journal-title":"Immunity"},{"key":"891_CR15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1074\/jbc.M708568200","volume":"283","author":"JH Kim","year":"2008","unstructured":"Kim JH, Kim JE, Liu HY, Cao W, Chen J. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J Biol Chem. 2008;283:708\u201315.","journal-title":"J Biol Chem"},{"key":"891_CR16","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1073\/pnas.0702596104","volume":"104","author":"J Zhou","year":"2007","unstructured":"Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, et al. Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA. 2007;104:16158\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"891_CR17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950\u20137.","journal-title":"Nat Immunol"},{"key":"891_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1359-6101(98)80005-1","volume":"8","author":"T Hirano","year":"1997","unstructured":"Hirano T, Nakajima K, Hibi M. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 1997;8:241\u201352.","journal-title":"Cytokine Growth Factor Rev"},{"key":"891_CR19","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","volume":"179","author":"TJ Harris","year":"2007","unstructured":"Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179:4313\u20137.","journal-title":"J Immunol"},{"key":"891_CR20","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/sj.onc.1203481","volume":"19","author":"T Decker","year":"2000","unstructured":"Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene. 2000;19:2628\u201337.","journal-title":"Oncogene"},{"key":"891_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol. 2011;12:295\u2013303.","journal-title":"Nat Immunol"},{"key":"891_CR22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.immuni.2009.06.002","volume":"30","author":"IC Ho","year":"2009","unstructured":"Ho IC. m(en)TOR(ing) differentiating T helper cells. Immunity. 2009;30:759\u201361.","journal-title":"Immunity"},{"key":"891_CR23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"key":"891_CR24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10875-009-9328-2","volume":"30","author":"J Ge","year":"2010","unstructured":"Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol. 2010;30:60\u20137.","journal-title":"J Clin Immunol"},{"key":"891_CR25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1440-1746.2009.06154.x","volume":"25","author":"W Wu","year":"2010","unstructured":"Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol. 2010;25:750\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"891_CR26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10875-010-9416-3","volume":"30","author":"Y Ye","year":"2010","unstructured":"Ye Y, Xie X, Yu J, Zhou L, Xie H, Jiang G, et al. Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol. 2010;30:546\u201355.","journal-title":"J Clin Immunol"},{"key":"891_CR27","first-page":"58","volume":"1","author":"C Johnson","year":"2012","unstructured":"Johnson C, Han Y, Hughart N, McCarra J, Alpini G, Meng F. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer. 2012;1:58\u201370.","journal-title":"Transl Gastrointest Cancer"},{"key":"891_CR28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2005.02.048","volume":"43","author":"XP Yang","year":"2005","unstructured":"Yang XP, Schaper F, Teubner A, Lammert F, Heinrich PC, Matern S, et al. Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo. J Hepatol. 2005;43:704\u201310.","journal-title":"J Hepatol"},{"key":"891_CR29","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","volume":"50","author":"M Hosel","year":"2009","unstructured":"Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, Broxtermann M, et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology. 2009;50:1773\u201382.","journal-title":"Hepatology"},{"key":"891_CR30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/intimm\/dxm045","volume":"19","author":"M Nishihara","year":"2007","unstructured":"Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17\u00a0+\u00a0Th with a minimum effect on that of Treg in the steady state. Int Immunol. 2007;19:695\u2013702.","journal-title":"Int Immunol"},{"key":"891_CR31","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2741\/4054","volume":"17","author":"A Camporeale","year":"2012","unstructured":"Camporeale A, Poli V. IL-6, IL-17 and STAT3: a holy trinity in auto-immunity? Front Biosci. 2012;17:2306\u201326.","journal-title":"Front Biosci"},{"key":"891_CR32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","volume":"12","author":"H Chi","year":"2012","unstructured":"Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol. 2012;12:325\u201338.","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0891-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-013-0891-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0891-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T09:05:54Z","timestamp":1564995954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-013-0891-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,25]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1007\/s00535-013-0891-1","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,25]]}}}